INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Laurus Labs Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 540222	ISIN Demat INE947Q01028	Book Value 79.18	NSE Symbol LAURUSLABS	Dividend Yield (%) 0.13	Market Cap (₹ Cr.) 32,684.09	P/E 130.91	EPS 4.63	Face Value 2

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	4,812.39	5,773.45	4,707.04	4,768.72	2,797.34
Sale of Products	4,620.28	5,628.19	4,526.28	4,569.13	2,664.09
Sale of Services	153.91	114.13	132.74	123.10	60.53
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	38.20	31.13	48.02	76.49	72.72
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	4,812.39	5,773.45	4,707.04	4,768.72	2,797.34
Other Income	47.42	15.95	21.55	27.32	5.81
Total Revenue	4,859.81	5,789.40	4,728.59	4,796.04	2,803.15
Changes in Inventories	-102.48	40.82	-218.62	-296.45	-218.09
Cost of Material Consumed	2,396.95	2,515.94	2,281.37	2,375.35	1,604.76
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	110.92	155.71	145.81	96.23	15.88
Employee Benefits	552.21	496.57	445.14	401.88	324.00
Total Other Expenses	1,104.91	1,082.65	768.14	681.84	500.56
Manufacturing / Operating Expenses	797.06	729.80	511.90	445.33	321.89
Administrative and Selling Expenses	278.23	308.55	240.91	226.03	168.05
Other Expenses	29.62	44.30	15.33	10.48	10.62
Finance Costs	150.82	145.70	95.86	65.92	87.71
Depreciation and Amortization	345.01	300.58	235.48	196.64	183.85
Total Expenses	4,558.34	4,737.97	3,753.18	3,521.41	2,498.67
Profit Before Exceptional Items and Tax	301.47	1,051.43	975.41	1,274.63	304.48
Exceptional Items Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	301.47	1,051.43	975.41	1,274.63	304.48
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	301.47	1,051.43	975.41	1,274.63	304.48
Taxation	77.77	291.05	225.32	318.52	37.43
Current Tax	87.94	270.78	231.42	334.98	53.00
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-10.17	20.27	-6.10	-16.46	-15.57
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	223.70	760.38	750.09	956.11	267.05
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	223.70	760.38	750.09	956.11	267.05
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	223.70	760.38	750.09	956.11	267.05
Earning Per Share - Basic	4.15	14.14	13.97	17.85	5.01
Earning Per Share - Diluted	4.15	14.09	13.91	17.77	5.01
Operation Profit before Depreciation	797.30	1,497.71	1,306.75	1,537.19	576.04
Operating Profit after Depreciation	452.29	1,197.13	1,071.27	1,340.55	392.19
Dividend Per Share	0.80	2.00	2.00	2.00	2.50
Dividend Percentage	40.00	100.00	100.00	100.00	25.00
Equity Dividend	43.10	107.41	107.41	107.28	26.66
Weighted Average Shares - Basic	53.87	53.77	53.68	53.57	53.34
Weighted Average Shares - Diluted	53.97	53.96	53.92	53.81	53.35